Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04679896 · ClinicalTrials.gov registry record · NA
Post Marketing Study of MagnetOs Putty Compared to Local Autograft in Patients Undergoing Posterolateral Lumbar Fusion
A NA study, sponsored by Kuros Biosurgery.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04679896 is a NA study that has completed, run by Kuros Biosurgery. The registered enrollment target is 30 participants.
The verdict
NCT04679896, a NA study, has completed, sponsored by Kuros Biosurgery.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a phase IV post-marketing study for MagnetOs Putty. MagnetOs Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with leg pain and/or back pain and undergoing spinal fusion surgery. In this study, MagnetOs Putty will be used according to the latest U.S. Instructions For Use, specifically as a bone graft extender mixed with autograft in a 1:1 vol.% in the posterolateral spine.
Interventions
- DEVICE MagnetOs Putty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2023-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04679896
The ClinicalTrials.gov registry entry for NCT04679896 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kuros Biosurgery, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MagnetOs Putty is the first listed.
NCT04679896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04679896 about?
NCT04679896 is a clinical study titled "Post Marketing Study of MagnetOs Putty Compared to Local Autograft in Patients Undergoing Posterolateral Lumbar Fusion". This is a phase IV post-marketing study for MagnetOs Putty. MagnetOs Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with leg pain and/or back pain and undergoing spinal fusion surgery. In this study, MagnetOs Putty will be used accord...
What is the current status of trial NCT04679896?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-08-13. Estimated completion is 2023-12-02.
What interventions are being tested in trial NCT04679896?
The interventions under investigation include: MagnetOs Putty (DEVICE).
Who is sponsoring clinical trial NCT04679896?
This trial is sponsored by Kuros Biosurgery, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.